182 related articles for article (PubMed ID: 31391454)
1. Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3.
Fu R; Yang P; Li Z; Liu W; Amin S; Li Z
Cell Death Dis; 2019 Aug; 10(8):593. PubMed ID: 31391454
[TBL] [Abstract][Full Text] [Related]
2. Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro.
Guo W; Nie L; Wu D; Wise ML; Collins FW; Meydani SN; Meydani M
Nutr Cancer; 2010; 62(8):1007-16. PubMed ID: 21058188
[TBL] [Abstract][Full Text] [Related]
3. Yeast-Derived Recombinant Avenanthramides Inhibit Proliferation, Migration and Epithelial Mesenchymal Transition of Colon Cancer Cells.
Finetti F; Moglia A; Schiavo I; Donnini S; Berta GN; Di Scipio F; Perrelli A; Fornelli C; Trabalzini L; Retta SF
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30149546
[TBL] [Abstract][Full Text] [Related]
4. Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.
Heerma van Voss MR; Vesuna F; Bol GM; Afzal J; Tantravedi S; Bergman Y; Kammers K; Lehar M; Malek R; Ballew M; Ter Hoeve N; Abou D; Thorek D; Berlinicke C; Yazdankhah M; Sinha D; Le A; Abrahams R; Tran PT; van Diest PJ; Raman V
Oncogene; 2018 Jan; 37(1):63-74. PubMed ID: 28869602
[TBL] [Abstract][Full Text] [Related]
5. Phenolic amides (avenanthramides) in oats - an update review.
Xie X; Lin M; Xiao G; Liu H; Wang F; Liu D; Ma L; Wang Q; Li Z
Bioengineered; 2024 Dec; 15(1):2305029. PubMed ID: 38258524
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative activity of vitexin-2-O-xyloside and avenanthramides on CaCo-2 and HepG2 cancer cells occurs through apoptosis induction and reduction of pro-survival mechanisms.
Scarpa ES; Antonini E; Palma F; Mari M; Ninfali P
Eur J Nutr; 2018 Jun; 57(4):1381-1395. PubMed ID: 28283822
[TBL] [Abstract][Full Text] [Related]
7. CQ synergistically sensitizes human colorectal cancer cells to SN-38/CPT-11 through lysosomal and mitochondrial apoptotic pathway via p53-ROS cross-talk.
Chen P; Luo X; Nie P; Wu B; Xu W; Shi X; Chang H; Li B; Yu X; Zou Z
Free Radic Biol Med; 2017 Mar; 104():280-297. PubMed ID: 28131902
[TBL] [Abstract][Full Text] [Related]
8. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of oat avenanthramides using hybrid quadrupole-Orbitrap mass spectrometry: Possible detection of new compounds.
Jágr M; Dvořáček V; Čepková PH; Doležalová J
Rapid Commun Mass Spectrom; 2020 May; 34(10):e8718. PubMed ID: 31896159
[TBL] [Abstract][Full Text] [Related]
10. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
11. A Computational Approach with Biological Evaluation: Combinatorial Treatment of Curcumin and Exemestane Synergistically Regulates DDX3 Expression in Cancer Cell Lines.
Rampogu S; Kim SM; Son M; Baek A; Park C; Lee G; Kim Y; Kim GS; Kim JH; Lee KW
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32512851
[TBL] [Abstract][Full Text] [Related]
12. Natural and synthetic avenanthramides activate caspases 2, 8, 3 and downregulate hTERT, MDR1 and COX-2 genes in CaCo-2 and Hep3B cancer cells.
Scarpa ES; Mari M; Antonini E; Palma F; Ninfali P
Food Funct; 2018 May; 9(5):2913-2921. PubMed ID: 29726862
[TBL] [Abstract][Full Text] [Related]
13. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
14. Absorption Rates and Mechanisms of Avenanthramides in a Caco-2 Cell Model and Their Antioxidant Activity during Absorption.
Chen C; Li T; Chen Z; Wang L; Luo X
J Agric Food Chem; 2020 Feb; 68(8):2347-2356. PubMed ID: 32026690
[TBL] [Abstract][Full Text] [Related]
15. The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway.
Chen YJ; Chen HP; Cheng YJ; Lin YH; Liu KW; Chen YJ; Hou MF; Wu YC; Lee YC; Yuan SS
Life Sci; 2013 Jun; 92(22):1081-92. PubMed ID: 23624232
[TBL] [Abstract][Full Text] [Related]
16. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L
J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009
[TBL] [Abstract][Full Text] [Related]
17. DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.
Tang J; Chen H; Wong CC; Liu D; Li T; Wang X; Ji J; Sung JJ; Fang JY; Yu J
Oncogene; 2018 May; 37(22):3006-3021. PubMed ID: 29535419
[TBL] [Abstract][Full Text] [Related]
18. DDX3 enhances oncogenic KRAS‑induced tumor invasion in colorectal cancer via the β‑catenin/ZEB1 axis.
Wu DW; Lin PL; Cheng YW; Huang CC; Wang L; Lee H
Oncotarget; 2016 Apr; 7(16):22687-99. PubMed ID: 27007150
[TBL] [Abstract][Full Text] [Related]
19. miR-128 Targets the SIRT1/ROS/DR5 Pathway to Sensitize Colorectal Cancer to TRAIL-Induced Apoptosis.
Lian B; Yang D; Liu Y; Shi G; Li J; Yan X; Jin K; Liu X; Zhao J; Shang W; Zhang R
Cell Physiol Biochem; 2018; 49(6):2151-2162. PubMed ID: 30257253
[TBL] [Abstract][Full Text] [Related]
20. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
Shriwas O; Priyadarshini M; Samal SK; Rath R; Panda S; Das Majumdar SK; Muduly DK; Botlagunta M; Dash R
Apoptosis; 2020 Apr; 25(3-4):233-246. PubMed ID: 31974865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
